HDAC9 and small cell lung carcinoma: Administration of HDACs inhibitors in murine models was observed to upregulate YAP through attenuation of the activity of the RE1-silencing transcription factor-corepressor-HDAC complex, hence suppressing metastasis and improving survival in SCLC [181].